Inventor
George P. Miljanich
Inventor
Redwood City, CA, US
Overview
Patents· 30 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes31%
C07KPeptides28%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations26%
G01NInvestigating or analysing materials by determining their chemical or physical properties8%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests3%
C07DHeterocyclic compounds2%
Y10TTechnical subjects covered by former us classification1%
PatentTitleYear
10,857,204Method for administering omega-conopeptide202010,434,178Formulations for the delivery of active ingredients201910,307,463Method for administering omega-conopeptide201910,112,95311,13-modified saxitoxins for the treatment of pain201810,106,54910',11'-modified saxitoxins useful for the treatment of pain20189,707,270'Method for administering ω-conopeptide'20179,700,624'Formulations for the delivery of active ingredients'20178,765,680'Method for administering omega-conopeptide'20148,653,033'Method for administering omega-conopeptide'20148,513,198'Pharmaceutical formulation for reducing pain'20138,268,774'Method for reducing pain'20127,977,307'Method for reducing pain with ziconotide and morphine'20117,956,030'Method for reducing pain with ziconotide and baclofen'20117,833,973'Pharmaceutical formulations for reducing pain'20107,524,812'Pharmaceutical formulation comprising ziconotide'20097,268,109'Method for reducing pain'20076,653,460'Voltage-gated calcium channel antagonist and method'20036,489,119'Analgesic screening method and composition'20026,156,726'Voltage-gated calcium channel antagonist and method'20006,136,786'Method for enhancing analgesia'20006,087,091'Method of selecting a compound for producing analgesia'20005,994,305'Method of treating inflammation'19995,859,186'Methods for producing analgesia'19995,824,645'Method of treating inflammation'19985,587,454'Omega conopeptide compositions'19965,559,095'Delayed treatment method of reducing ischemia-related neuronal damage'19965,424,218'Screening method for neuroprotective compounds'19955,264,371'Screening method for neuroprotective compounds'19935,189,020'Method of reducing neuronal damage using omega conotoxin peptides'19935,051,403'Method of treating ischemia-related neuronal damage'1991Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1991–1999Patents assigned to NEUREX CORP (8)· patent assignee history
1991–2020Based in Redwood City, CA, US· patent location history
1999–2009Patents assigned to ELAN PHARM INC (8)· patent assignee history
2010–2012Patents assigned to AZUR PHARMA INTERNAT LTD (4)· patent assignee history
2013–2014Patents assigned to JAZZ PHARMACEUTICALS INTERNAT LTD (3)· patent assignee history
2017–2019Patents assigned to ADYNXX INC (2)· patent assignee history
2017–2019Based in San Francisco, CA, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ELAN PHARM INC | 8 | 1999–2009 |
| NEUREX CORP | 8 | 1991–1999 |
| AZUR PHARMA INTERNAT LTD | 4 | 2010–2012 |
| JAZZ PHARMACEUTICALS INTERNAT LTD | 3 | 2013–2014 |
| ADYNXX INC | 2 | 2017–2019 |
Locations
| Location | Patents | Span |
|---|---|---|
| Redwood City, California, US | 28 | 1991–2020 |
| San Francisco, California, US | 2 | 2017–2019 |